NCT00003409View on ClinicalTrials.gov

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 1998

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

motexafin gadolinium

RADIATION

radiation therapy

Trial Locations (2)

95817

University of California Davis Cancer Center, Sacramento

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00003409 - Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter